期刊文献+

锂对慢性铝暴露大鼠脑内CDK5和PP2A表达的影响 被引量:4

Effects of lithium on CDK5 and PP2A expressions in chronic aluminum exposure rats
下载PDF
导出
摘要 目的研究锂对慢性铝暴露大鼠脑内周期蛋白依赖性激酶5(CDK5)和蛋白磷酸酯酶2A(PP2A)表达的影响,进一步探讨锂抑制tau蛋白磷酸化的作用机制。方法慢性铝暴露大鼠12只,随机分为锂治疗组和非治疗组。锂治疗组给予氯化锂[200mg/(kg·d)]溶液连续灌胃6周;非治疗组以等量生理盐水灌胃。另取6只同月龄非铝暴露大鼠为正常对照组。Morris水迷宫测试3组大鼠学习记忆功能;Western blotting检测大鼠大脑皮层及海马磷酸化tau蛋白、CDK5、PP2A的表达。结果慢性铝暴露非治疗组大鼠脑内磷酸化tau蛋白含量、CDK5表达明显高于正常对照组大鼠(P<0.05),且慢性铝暴露非治疗组大鼠脑内磷酸化tau蛋白含量与CDK5表达呈正相关(r=0.702,P=0.036)。锂治疗组大鼠脑内磷酸化tau蛋白含量、CDK5表达明显低于非治疗组(P<0.05),且锂治疗组大鼠脑内CDK5表达与磷酸化tau蛋白含量呈正相关(r=0.871,P=0.024),而正常组、锂治疗组和非治疗组大鼠皮层及海马PP2A含量无明显差异(P>0.05)。结论抑制脑内CDK5表达可能是锂降低tau蛋白过度磷酸化,减少大鼠脑内神经原纤维缠结的又一途径。 Objective To explore the effects of lithium on expressions of cyclin-dependent kinase 5 (CDK5) and protein phosphatase 2A (PP2A) in the brains of chronic aluminum exposure rats so as to further understand the mechanism of lithium's inhibition on tau phosphorylation. Methods We divided 12 chronic aluminum chloride exposure rats into treatment group and non-treatment group (6 rats in each). Treatment group was given lithium chloride (200 mg/kg·d) via gastric perfusion daily for 6 weeks,while the non-treatment group sodium chloride at the same dosage and the normal group (6 non-aluminum exposure rats of the same month old) without intervention. Six weeks later,all the rats received Morris water maze test for learning memory function; CDK5 and PP2A expressions and phosphorylated tau protein level in rat hippocampus were determined by Western blotting. Results Compared with normal group,non-treatment of chronic aluminum exposure group showed higher phosphorylated tau protein level and CDK5 expression in the brain (P0.05),and the level of phosphorylated tau had a significantly positive correlation with CDK5 expression (r=0.702,P=0.036). After 6 weeks' treatment with lithium,phosphorylated tau protein and CDK5 expression decreased significantly in the brain compared with those in non-treatment group (P0.01). Moreover,phosphorylated tau had a significantly positive correlation with the expression of CDK5 (r=0.871,P=0.024) in lithium treatment group. There was no significant difference in PP2A expression among treatment group,non-treatment group and normal group (P0.05). Conclusion Lithium may reduce tau phosphorylation and neurofibrillary tangle formation by inhibiting the expression of CDK5.
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2010年第4期463-466,共4页 Journal of Xi’an Jiaotong University(Medical Sciences)
关键词 阿尔茨海默病 TAU蛋白磷酸化 周期蛋白依赖性激酶5 蛋白磷酸酯酶2A Alzheimer's disease lithium tau phosphorylation cyclin dependent kinase 5 protein phosphatase 2A
  • 相关文献

参考文献15

  • 1IQBAL K, ALONSO ADEL C, CHEN S, et al. Tau pathology in Alzheimer disease and other tauopathies [J]. Biochim Biophys Acta, 2005, 1739(2-3) :198-210.
  • 2NOBLE W, OLM V, TAKATA K, et al. Cdk5 is a key factor in tau aggregation and tangle formation in vivo [J]. Neuron, 2003, 38(4) :555-565.
  • 3VOGELSBERG-RAGAGLIA V, SCHUCK T, TROJANOWSKI JQ, et al. PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus [J]. Exp Neurol, 2001, 168(2) :402-412.
  • 4SUNA X, SATOA S, MURAYAMAA O, et al. Lithium inhibits amyloid secretion in COS7 ceils transfected with amyloid precursor protein C100 [J]. Neurosci Lett, 2002, 321(1-2)61-64.
  • 5Engel T, Ooni-Oliver P, Lucas JJ, et al. Chronic lithium administration to FTDP-17 tau and GSK-3 overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert [J]. J Neurochem, 2006, 99(6):1445-1455.
  • 6SU Y, RYDER J, LI B, etal. Lithium, a common drug for bipolar disorder treatment, regulates arnyloid-beta precursor protein processing[J]. Biochemistry, 2004, 43(22) : 6899-6908.
  • 7NOCJAR C, HAMMONDS, SHIM SS. Chronic lithium treatment magnifies learning in rats[J]. Neuroscience, ?007, 150 (4):774-788.
  • 8TERAO T, NAKANO H, INOUE Y, et al. Lithium and dementia:A preliminary study [J]. Prog Neuro-Psychopharmacol Biol Psychiatry, 2006, 30(6) : 1125-1128.
  • 9DUNN N, HOLMES C, MULLEE M. Does lithium therapy protect against the onset of dementia[J]. Alzheimer Dis Assoc Disord, 2005, 19(1) :20-22.
  • 10钱亦华,杨杰,任惠民,胡海涛,张樟进.痴呆模型大鼠背海马结构内淀粉样蛋白沉积的免疫细胞化学研究[J].西安医科大学学报,1997,18(3):304-307. 被引量:27

共引文献26

同被引文献77

  • 1宋锦秋,陈晓春.MAPK信号通路与阿尔茨海默病中tau蛋白磷酸化的关系[J].国际神经病学神经外科学杂志,2006,33(4):339-343. 被引量:14
  • 2施建华,钱慰,丁绍红,尹晓敏,沈勤,刘飞.蛋白激酶A催化微管相关蛋白tau磷酸化的研究[J].江苏大学学报(医学版),2006,16(6):485-488. 被引量:3
  • 3邢伟,王彪,许金华,李晓枫,聂海祺,张玉霞,时利德.慢性染铝大鼠海马PKC、MAPK活力与LTP的相关性[J].毒理学杂志,2007,21(2):102-104. 被引量:9
  • 4Petersen RC, Smith GE, Waring SC,et al. Mild cognitive impair- ment clinical characterization and outcome[J]. Arch Neurol, 1999, 56(6) :303.
  • 5McKelvey R, Bergman H, Stern J. Lack of prognostic significance of SPECT abnormalities in elderly subjects with a mild memory loss[J]. Can J Neurol Sci, 1999,26:23 - 28.
  • 6Phiel CJ,Wilson CA,Lee VM,et al. GSK- 3 alpha regulates pro- duction of Alzheimer' s disease amyloid beta peptides[J]. Nature, 2003,423(6938) : 435 -- 439.
  • 7Grundkeiqbal I, Iqbal K, Quinlan MT, et al. Microtubule - associat- ed protein tau, A component of Alzheimer paired helical filaments [J].J BiolChem,1986,261:6084- 6089.
  • 8Bruno D, Martin LA. Amnestic MCI or prodromal Alzheimer's disease[J]. The Lancet Neurology, 2010(4) : 1474.
  • 9McGeer PI., Schulzer M, McGeer GE. Arthritis and anti- inflam- matory agents as possible protective factors for Alzheimer' s dis- ease: A review of 17 epidemiologic studies[J]. Neurology, 1996,47 (2) :425 - 432.
  • 10Ebmt M,Loosen P,Numombe B,et al.Current diagnosis and treatment psychiatry[M].2th ed.New York:McGrawHill Press,2008:306.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部